文献
J-GLOBAL ID:201802212935647349
整理番号:18A1723901
過活動膀胱患者における単独療法と比較したミラベグロンとソリフェナシンの長期安全性と有効性:無作為化多施設第3相試験(相乗的II)【JST・京大機械翻訳】
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)
著者 (13件):
Gratzke Christian
(University of Munich, Munich, Germany)
,
van Maanen Rob
(Astellas Pharma Global Development, Leiden, The Netherlands)
,
Chapple Christopher
(Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK)
,
Abrams Paul
(Bristol Urological Institute, Southmead Hospital, Bristol, UK)
,
Herschorn Sender
(University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Canada)
,
Robinson Dudley
(King’s College Hospital, London, UK)
,
Ridder Arwin
(Astellas Pharma Global Development, Leiden, The Netherlands)
,
Stoelzel Matthias
(Astellas Pharma Global Development, Leiden, The Netherlands)
,
Paireddy Asha
(Astellas Pharma Global Development, Leiden, The Netherlands)
,
Yoon Sang Jin
(Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, South Korea)
,
Al-Shukri Salman
(Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia)
,
Rechberger Tomasz
(Medical University of Lublin, Lublin, Poland)
,
Mueller Elizabeth R.
(Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA)
資料名:
European Urology
(European Urology)
巻:
74
号:
4
ページ:
501-509
発行年:
2018年
JST資料番号:
A0910B
ISSN:
0302-2838
CODEN:
EUURAV
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)